These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 392049)

  • 1. Peptide transport in Candida albicans.
    Logan DA; Becker JM; Naider F
    J Gen Microbiol; 1979 Sep; 114(1):179-86. PubMed ID: 392049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecificity of tripeptide utilization in a methionine auxotroph of Escherichia coli K-12.
    Becker JM; Naider F
    J Bacteriol; 1974 Oct; 120(1):191-6. PubMed ID: 4608021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplicity of oligopeptide transport systems in Escherichia coli.
    Naider F; Becker JM
    J Bacteriol; 1975 Jun; 122(3):1208-15. PubMed ID: 1097395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity inhibition of peptide transport in yeast.
    Sarthou P; Gonneau M; Le Goffic F
    Biochem Biophys Res Commun; 1983 Feb; 110(3):884-9. PubMed ID: 6340670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proline uptake in Candida albicans.
    Dabrowa N; Howard DH
    J Gen Microbiol; 1981 Dec; 127(2):391-7. PubMed ID: 7045279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide utilization by Pseudomonas putida and Pseudomonas maltophilia.
    Cascieri T; Mallette MF
    J Gen Microbiol; 1976 Feb; 92(2):283-95. PubMed ID: 1255131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity myo-inositol transport in Candida albicans: substrate specificity and pharmacology.
    Jin JH; Seyfang A
    Microbiology (Reading); 2003 Dec; 149(Pt 12):3371-3381. PubMed ID: 14663071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basis for the design of anticandidal agents from studies of peptide utilization in Canadida albicans.
    Lichliter WD; Naider F; Becker JM
    Antimicrob Agents Chemother; 1976 Sep; 10(3):483-90. PubMed ID: 791103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligopeptide transport in proline peptidase mutants of Salmonella typhimurium.
    Jackson MB; Becker JM
    J Biol Chem; 1976 Sep; 251(17):5300-9. PubMed ID: 783159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide uptake in Candida albicans.
    Davies MB
    J Gen Microbiol; 1980 Nov; 121(1):181-6. PubMed ID: 7019386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-associated collagenolytic activity by Candida albicans.
    Nishimura M; Nikawa H; Yamashiro H; Nishimura H; Hamada T; Embery G
    Mycopathologia; 2002; 153(3):125-8. PubMed ID: 11998872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080.
    Nakanishi T; Tamai I; Sai Y; Sasaki T; Tsuji A
    Cancer Res; 1997 Sep; 57(18):4118-22. PubMed ID: 9307302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport mechanism of (11)C-labeled L- and D-methionine in human-derived tumor cells.
    Kobayashi M; Hashimoto F; Ohe K; Nadamura T; Nishi K; Shikano N; Nishii R; Higashi T; Okazawa H; Kawai K
    Nucl Med Biol; 2012 Nov; 39(8):1213-8. PubMed ID: 22795787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization of lucifer yellow in Candida albicans by fluid phase endocytosis.
    Basrai MA; Naider F; Becker JM
    J Gen Microbiol; 1990 Jun; 136(6):1059-65. PubMed ID: 2200841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aminolaevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line.
    Gederaas OA; Holroyd A; Brown SB; Vernon D; Moan J; Berg K
    Photochem Photobiol; 2001 Feb; 73(2):164-9. PubMed ID: 11272730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cell penetration of the antifungal peptide, MMGP1, in Candida albicans.
    Pushpanathan M; Rajendhran J; Jayashree S; Sundarakrishnan B; Jayachandran S; Gunasekaran P
    J Pept Sci; 2012 Nov; 18(11):657-60. PubMed ID: 23080316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of pyrimidines and their derivatives into Candida glabrata and Candida albicans.
    Fasoli MO; Kerridge D
    J Gen Microbiol; 1990 Aug; 136(8):1475-81. PubMed ID: 2262788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of oxalysine and oxalysine-containing peptides against Candida albicans: regulation of peptide transport by amino acids.
    Basrai MA; Zhang HL; Miller D; Naider F; Becker JM
    J Gen Microbiol; 1992 Nov; 138(11):2353-62. PubMed ID: 1479355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and anti-Candida albicans properties of L-4-oxalysine-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic-containing peptide analogues].
    Feng S; Xu X; Zhang H
    Yao Xue Xue Bao; 1998 Jun; 33(6):429-35. PubMed ID: 12016912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Candida activity of cispentacin: the active transport by amino acid permeases and possible mechanisms of action.
    Capobianco JO; Zakula D; Coen ML; Goldman RC
    Biochem Biophys Res Commun; 1993 Feb; 190(3):1037-44. PubMed ID: 8439305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.